AngioDynamics, Inc. (ANGO) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $10.47. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ANGO = $58.08 (+454.7% from the current price, the stock appears undervalued). Analyst consensus target is ANGO = $17 (+57.6% upside).
Valuation: ANGO trades at a trailing Price-to-Earnings (P/E) of -13.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 6.63.
Financials: revenue is $292M, -2.3%/yr average growth. Net income is $34M (loss), growing at -89.2%/yr. Net profit margin is -11.6% (negative). Gross margin is 53.9% (+1.5 pp trend).
Balance sheet: total debt is $0 against $183M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.21 (strong liquidity). Debt-to-assets is 0%. Total assets: $280M.
Analyst outlook: 5 / 11 analysts rate ANGO as buy (45%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 52/100 (Partial), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 54/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
